Echo Therapeutics Inc (ECTE) financial statements (2020 and earlier)
Company profile
| Business Address |
99 WOOD AVENUE SOUTH ISELIN, NJ 08830 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 9/30/2016 TTM | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 0 | 1 | 8 | 4 | |||
| Cash and cash equivalents | 0 | 1 | 8 | 4 | |||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | 0 | ||
| Other undisclosed current assets | 0 | 1 | 1 | 1 | |||
| Total current assets: | 0 | 2 | 9 | 5 | |||
| Noncurrent Assets | |||||||
| Property, plant and equipment | 1 | 1 | 2 | ||||
| Intangible assets, net (including goodwill) | 10 | 10 | 10 | ||||
| Intangible assets, net (excluding goodwill) | 10 | 10 | 10 | ||||
| Deposits noncurrent assets | 0 | ||||||
| Deferred costs | 3 | 1 | |||||
| Other noncurrent assets | 0 | 0 | 0 | ✕ | |||
| Other undisclosed noncurrent assets | 0 | (1) | (1) | 1 | |||
| Total noncurrent assets: | 0 | 10 | 12 | 13 | |||
| Other undisclosed assets | 0 | 1 | 1 | 2 | |||
| TOTAL ASSETS: | 1 | 13 | 23 | 20 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 3 | 3 | 2 | 4 | |||
| Accounts payable | 2 | 2 | 1 | 2 | |||
| Accrued liabilities | 1 | 1 | 1 | 2 | |||
| Debt | 0 | 0 | |||||
| Derivative instruments and hedges, liabilities | 0 | 0 | 1 | 6 | |||
| Deferred revenue and credits | 0 | 0 | |||||
| Other undisclosed current liabilities | 0 | ||||||
| Total current liabilities: | 3 | 3 | 4 | 10 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation, including: | 0 | ||||||
| Other undisclosed long-term debt and lease obligation | 0 | ||||||
| Liabilities, other than long-term debt | 0 | 0 | 0 | 0 | |||
| Deferred revenue and credits | 0 | 0 | 0 | 0 | |||
| Other undisclosed noncurrent liabilities | 0 | ||||||
| Total noncurrent liabilities: | 0 | 0 | 0 | 0 | |||
| Total liabilities: | 3 | 3 | 4 | 10 | |||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent, including: | (3) | 10 | 19 | 10 | |||
| Common stock | 0 | 0 | 0 | 0 | |||
| Additional paid in capital | 147 | 137 | 132 | 104 | |||
| Accumulated deficit | (150) | (128) | (113) | (94) | |||
| Warrants and rights outstanding | 1 | 13 | |||||
| Other undisclosed stockholders' equity attributable to parent | 0 | 0 | (1) | (13) | |||
| Total stockholders' equity: | (3) | 10 | 19 | 10 | |||
| TOTAL LIABILITIES AND EQUITY: | 1 | 13 | 23 | 20 | |||
Income statement (P&L) ($ in millions)
| 9/30/2016 TTM | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|
| Revenue, net | 0 | 0 | 0 | |||
| Financial services revenue | 0 | 1 | ||||
| Gross profit: | 0 | 1 | 0 | 0 | ||
| Operating expenses | (18) | (12) | (20) | (15) | ||
| Other undisclosed operating loss | (0) | (1) | ||||
| Operating loss: | (18) | (12) | (20) | (15) | ||
| Nonoperating income (expense) | (5) | (3) | 1 | 3 | ||
| Loss on sale of capital leases, net | (5) | |||||
| Interest and debt expense | (0) | (4) | (4) | 0 | ||
| Loss from continuing operations before income taxes: | (22) | (19) | (23) | (12) | ||
| Income tax expense | (0) | (0) | ||||
| Net loss: | (22) | (19) | (23) | (12) | ||
| Other undisclosed net income (loss) attributable to parent | 0 | 4 | 4 | (0) | ||
| Net loss attributable to parent: | (22) | (15) | (19) | (12) | ||
| Other undisclosed net loss available to common stockholders, basic | (0) | (0) | ||||
| Net loss available to common stockholders, diluted: | (22) | (15) | (19) | (12) | ||
Comprehensive Income ($ in millions)
| 9/30/2016 TTM | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|
| Net loss: | (22) | (19) | (23) | (12) | ||
| Comprehensive loss, net of tax, attributable to parent: | (22) | (19) | (23) | (12) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.